{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:45:54Z","timestamp":1794019554380,"version":"4.8.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Global Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>AMR is an important global public health challenge, but there is a lack of good data on response progress. This study addresses country governance of antimicrobial resistance (AMR) surveillance, considering changes in responses to the Tracking Antimicrobial Resistance Country Self-Assessment Survey (TrACSS) between 2019 and 2024. Its first objective is to describe progress under the global action agenda on AMR. Its second objective is to assess the effectiveness of a major development aid intervention to encourage action against AMR, the United Kingdom (UK)-funded Fleming Fund (FF). The study applies a pragmatic approach to analysis, involving descriptive exploration and difference-in-differences methodology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Governance of AMR surveillance in low- and middle-income countries generally strengthened over the five years to 2024, converging with high-income countries (HIC). South-East Asian countries reported relatively strong gains, a striking exception to limited global progress. Globally, over fifteen indicators, clear progress was only reported in four: two on strengthening underlying AMR surveillance systems, in both human health (HH) and animal health (AH); and two on regulatory frameworks in AH. FF-supported countries reported strengthening HH surveillance systems more than comparable countries, even accounting for income-group differences. The standardised change score for the \u2018national surveillance system for AMR in humans\u2019 was 0.11 higher in FF-supported than in other Official Development Assistance (ODA)-eligible countries (95% confidence level,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.046). FF-supported countries also reported greater progress on other topics, such as use of surveillance data for decision-making in AH. FF-supported countries were approximately a quarter (25%) more likely to respond \u2018yes\u2019 on this topic. Additional reflections on the strengths and weaknesses of TrACSS data are discussed in detail.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study adds empirical observations about country governance systems as they relate to AMR surveillance efforts. The idea of progressive global momentum, with South-East Asia playing a key role, disrupts established perceptions of European leadership and obstacles to change. From an aid effectiveness perspective, this study indicates that FF strengthened country HH and AH surveillance systems. It also points to institutional changes in how data are used in administrative decision-making processes and, potentially, in the translation of evidence into policy, programmes and regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12992-025-01179-4","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:47:46Z","timestamp":1767768466000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Country governance of antimicrobial resistance (AMR) surveillance: observations on global progress and aid programme effectiveness using data from the Tracking AMR Country Self-Assessment Survey (TrACSS)"],"prefix":"10.1186","volume":"22","author":[{"given":"Archie","family":"Drake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Sassoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Maudling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Gupta-Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anila","family":"Shafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Shorten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"1179_CR1","unstructured":"WHO. Global action plan on antimicrobial resistance [Internet]. 2016. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509763."},{"key":"1179_CR2","unstructured":"WHO. Global database for tracking antimicrobial resistance (AMR) country self- assessment survey (TrACSS) [Internet]. 2025. Available from: http:\/\/amrcountryprogress.org\/."},{"key":"1179_CR3","unstructured":"Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet [Internet]. 2022. Available from: https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(21)02724-0\/fulltext."},{"issue":"10459","key":"1179_CR4","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990-2021. A systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199\u2013226.","journal-title":"Lancet"},{"issue":"7","key":"1179_CR5","doi-asserted-by":"publisher","first-page":"e1004265","DOI":"10.1371\/journal.pmed.1004265","volume":"20","author":"S Bertagnolio","year":"2023","unstructured":"Bertagnolio S, Suthar AB, Tosas O, Weezenbeek KV. Antimicrobial resistance: strengthening surveillance for public health action. PLoS Med. 2023;20(7):e1004265.","journal-title":"PLoS Med"},{"issue":"1","key":"1179_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12879-023-08585-2","volume":"23","author":"PC Do","year":"2023","unstructured":"Do PC, Assefa YA, Batikawai SM, Reid SA. Strengthening antimicrobial resistance surveillance systems: a scoping review. BMC Infect Dis. 2023;23(1):593.","journal-title":"BMC Infect Dis"},{"issue":"25","key":"1179_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jgar.2021.03.016","volume":"1","author":"I Frost","year":"2021","unstructured":"Frost I, Kapoor G, Craig J, Liu D, Laxminarayan R. Status, challenges and gaps in antimicrobial resistance surveillance around the world. J Glob Antimicrob Resist. 2021;1(25):222\u201326.","journal-title":"J Glob Antimicrob Resist"},{"key":"1179_CR8","unstructured":"World Bank. World Bank. Landscape analysis of tools to address antimicrobial resistance. 2021. Available from: https:\/\/thedocs.worldbank.org\/en\/doc\/e9d15ce04da6b28e0013dfca2cd2426f-0140012021\/original\/Landscape-Analysis-of-Tools-to-Address-AMR-Circulation-Copy-May-13-2021.pdf."},{"issue":"11","key":"1179_CR9","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S1473-3099(19)30415-3","volume":"19","author":"M Anderson","year":"2019","unstructured":"Anderson M, Schulze K, Cassini A, Plachouras D, Mossialos E. A governance framework for development and assessment of national action plans on antimicrobial resistance. Lancet Infect Dis. 2019;19(11):e371\u201384.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"1179_CR10","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/S2542-5196(18)30186-4","volume":"2","author":"P Collignon","year":"2018","unstructured":"Collignon P, Beggs JJ, Walsh TR, Gandra S, Laxminarayan R. Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis. Lancet Planet Health. 2018;2(9):e398\u2013405.","journal-title":"Lancet Planet Health"},{"issue":"1","key":"1179_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12992-023-00913-0","volume":"19","author":"A Maugeri","year":"2023","unstructured":"Maugeri A, Barchitta M, Puglisi F, Agodi A. Socio-economic, governance and health indicators shaping antimicrobial resistance: an ecological analysis of 30 European countries. Glob Health. 2023;19(1):12.","journal-title":"Glob Health"},{"key":"1179_CR12","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/one.2023.13","volume":"2","author":"A Ruckert","year":"2024","unstructured":"Ruckert A, Harris F, Aenishaenslin C, Aguiar R, Boudreau-LeBlanc A, Carmo LP, et al. One health governance principles for AMR surveillance: a scoping review and conceptual framework. Res Dir One Health. 2024;2:e4.","journal-title":"Res Dir One Health"},{"key":"1179_CR13","doi-asserted-by":"crossref","unstructured":"Patel J, Harant A, Fernandes G, Mwamelo AJ, Hein W, Dekker D, et al. Measuring the global response to antimicrobial resistance, 2020-21. A systematic governance analysis of 114 countries. Lancet Infect Dis. 2023;23(6):706\u201318.","DOI":"10.1016\/S1473-3099(22)00796-4"},{"key":"1179_CR14","unstructured":"Patel J, Moghaddam SS, Ranganathan S, Vezeau N, O\u2019Neill E, Harant A, et al. Global policy responses to antimicrobial resistance, 2021-22. A systematic governance analysis of 161 countries and territories. Lancet Infect Dis [Internet]. 2025; Available from: https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(25)00406-2\/fulltext."},{"issue":"1","key":"1179_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13756-022-01130-x","volume":"11","author":"A Willemsen","year":"2022","unstructured":"Willemsen A, Reid S, Assefa Y. A review of national action plans on antimicrobial resistance: strengths and weaknesses. Antimicrob Resist Infect Control. 2022;11(1):90.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"1179_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/pad.1966","volume":"42","author":"O Rubin","year":"2022","unstructured":"Rubin O, Munkholm L. Isomorphic dynamics in national action plans on antimicrobial resistance. Public Adm Dev. 2022;42(2):142\u201353.","journal-title":"Public Adm Dev"},{"key":"1179_CR17","doi-asserted-by":"crossref","unstructured":"Carelli DE, Mitsouli ET, Ogne JB, Pierre J. The best laid plans? International governance perspectives in AMR national action plans in Europe. Eur J Public Health. 2023;33(4):682\u201386.","DOI":"10.1093\/eurpub\/ckad080"},{"key":"1179_CR18","unstructured":"Fleming Fund. Fleming Fund. 2025 [cited 2025 Apr 24]. Fleming Fund. Available from: https:\/\/www.flemingfund.org\/."},{"key":"1179_CR19","unstructured":"Itad. Fleming Fund. 2023 [cited 2025 Apr 24]. Fleming Fund Phase I Evaluation. Available from: https:\/\/www.flemingfund.org\/publications\/fleming-fund-phase-i-evaluation\/."},{"key":"1179_CR20","doi-asserted-by":"crossref","unstructured":"Kumar M, Gotz D, Nutley T, Smith JB. Research gaps in routine health information system design barriers to data quality and use in low- and middle-income countries: a literature review. Int J Health Plann Manage. 2018;33(1):e1\u20139.","DOI":"10.1002\/hpm.2447"},{"key":"1179_CR21","unstructured":"AMR, Quadripartite Joint Secretariat on about - Technical work [Internet]. 2025. Available from: https:\/\/www.qjsamr.org\/technical-work\/about."},{"key":"1179_CR22","unstructured":"WHO. Tracking AMR country Self-assessment survey - TrACSS (7.0) 2023 [Internet]. 2023. Available from: https:\/\/www.who.int\/publications\/m\/item\/tracking-amr-country-self-assessment-survey-tracss-(7.0)-2023."},{"key":"1179_CR23","doi-asserted-by":"crossref","unstructured":"Gahimbare L, Mwamelo AJ, Ahmed YA, Fuller W, Payidara P, Prakash P, et al. Monitoring progress on antimicrobial resistance response in the who African region: insights from the TrACSS 2021. Results for the human health sector. J Public Health Afr. 2023;14(11):13.","DOI":"10.4081\/jphia.2023.2392"},{"key":"1179_CR24","doi-asserted-by":"publisher","first-page":"107188","DOI":"10.1016\/j.phrs.2024.107188","volume":"204","author":"M Sabbatucci","year":"2024","unstructured":"Sabbatucci M, Ashiru-Oredope D, Barbier L, Bohin E, Bou-Antoun S, Brown C, et al. Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017-2023. opportunities and gaps. Pharmacol Res. 2024;204:107188.","journal-title":"Pharmacol Res"},{"key":"1179_CR25","unstructured":"OECD. OECD. Embracing a one health framework to fight antimicrobial resistance. 2023. Available from: https:\/\/www.oecd.org\/en\/publications\/embracing-a-one-health-framework-to-fight-antimicrobial-resistance_19407037-en.html."},{"key":"1179_CR26","unstructured":"World Bank Governance & Documents | The Pandemic Fund [Internet]. 2024 [cited 2025 May 21]. Available from: https:\/\/www.thepandemicfund.org\/governance-documents."},{"key":"1179_CR27","unstructured":"R Core Team. R: a language and environment for statistical computing [Internet]. Vienna, Austria: R Foundation for Statistical Computing. 2024. Available from: https:\/\/www.R-project.org\/."},{"key":"1179_CR28","unstructured":"WHO Global database for tracking antimicrobial resistance (AMR) country self- assessment survey (TrACSS) [Internet]. 2023 [cited 2025 Apr 24]. Available from: http:\/\/amrcountryprogress.org\/."},{"key":"1179_CR29","unstructured":"WHO Global database for tracking antimicrobial resistance (AMR) country self- assessment survey (TrACSS) [Internet]. 2024 [cited 2025 Apr 24]. Available from: https:\/\/new.amrcountryprogress.org\/."},{"key":"1179_CR30","unstructured":"Fleming Fund. The Fleming Fund 2021 Annual Review [Internet]. Fleming Fund. 2022 [cited 2025 Nov 25]. Available from: https:\/\/www.flemingfund.org\/publications\/the-fleming-fund-2021-annual-review\/."},{"key":"1179_CR31","unstructured":"World Bank World Bank Country and Lending Groups - World Bank Data Help Desk [Internet]. 2024 [cited 2025 May 2]. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups."},{"issue":"4","key":"1179_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1108\/RAUSP-05-2019-0112","volume":"54","author":"A Fredriksson","year":"2019","unstructured":"Fredriksson A, de Oliveira GM. Impact evaluation using difference-in-differences. RAUSP Manag J. 2019;54(4):519\u201332.","journal-title":"RAUSP Manag J"},{"key":"1179_CR33","unstructured":"OECD webfs.oecd.org -\/oda\/DAClists\/[Internet]. 2024 [cited 2025 May 2]. Available from: https:\/\/webfs.oecd.org\/oda\/DAClists\/."},{"key":"1179_CR34","unstructured":"World Bank World Development Indicators | DataBank [Internet]. 2024 [cited 2025 May 2]. Available from: https:\/\/databank.worldbank.org\/source\/world-development-indicators."},{"key":"1179_CR35","unstructured":"IHME AMR policy briefings by country | Institute for Health Metrics and Evaluation [Internet]. 2024 [cited 2025 May 2]. Available from: https:\/\/www.healthdata.org\/antimicrobial-resistance\/policy-briefings."},{"issue":"12","key":"1179_CR36","doi-asserted-by":"publisher","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","volume":"5","author":"AJ Browne","year":"2021","unstructured":"Browne AJ, Chipeta MG, Haines-Woodhouse G, Kumaran EPA, Hamadani BHK, Zaraa S, et al. Global antibiotic consumption and usage in humans, 2000-18. A spatial modelling study. Lancet Planet Health. 2021;5(12):e893\u2013904.","journal-title":"Lancet Planet Health"},{"key":"1179_CR37","unstructured":"GRAM Antibiotic usage and consumption [Internet] 2024 [cited 2025 May 2]. Available from: https:\/\/www.tropicalmedicine.ox.ac.uk\/gram\/research\/visualisation-app-antibiotic-usage-and-consumption."},{"issue":"1","key":"1179_CR38","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1186\/s12889-024-19542-2","volume":"24","author":"K Zay Ya","year":"2024","unstructured":"Zay Ya K, Lambiris MJ, Levine GA, Tediosi F, Fink G. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the global survey of experts on antimicrobial resistance. BMC Public Health. 2024;24(1):2297.","journal-title":"BMC Public Health"},{"key":"1179_CR39","unstructured":"Sullivan C, Fisher CR, Grabowsky L, Sertkaya A, Berlind A, Mallick S Combating antimicrobial resistance during the COVID-19 pandemic: perceived risks and protective practices: report [Internet]. Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE). (HHS ASPE Reports). 2025 [cited 2025 June 4]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK611796\/."},{"issue":"2","key":"1179_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/14787210.2021.1951705","volume":"20","author":"G Sulis","year":"2022","unstructured":"Sulis G, Sayood S, Gandra S. Antimicrobial resistance in low- and middle-income countries: current status and future directions. Expert Rev Anti Infect Ther. 2022;20(2):147\u201360.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"2","key":"1179_CR41","doi-asserted-by":"publisher","first-page":"e0297921","DOI":"10.1371\/journal.pone.0297921","volume":"19","author":"S Ajulo","year":"2024","unstructured":"Ajulo S, Awosile B. Global antimicrobial resistance and use surveillance system (GLASS 2022): investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries. PLoS ONE. 2024;19(2):e0297921.","journal-title":"PLoS One"},{"key":"1179_CR42","unstructured":"FAO. AMR-LEX - laws, regulations and policies relevant to combat antimicrobial resistance (AMR) within the context of agri-food systems [Internet]. 2025. Available from: https:\/\/amr-lex.fao.org\/."},{"key":"1179_CR43","unstructured":"WOAH Towards a healthier future for all: progress in animal health to contain antimicrobial resistance [Internet]. WOAH - World Organisation for Animal Health. 2024 [cited 2025 May 9]. Available from: https:\/\/www.woah.org\/en\/document\/towards-a-healthier-future-for-all-progress-in-animal-health-to-contain-amr\/."},{"key":"1179_CR44","unstructured":"WHO Un general assembly high-level meeting on antimicrobial resistance 2024 [Internet]. 2024 [cited 2025 Apr 24]. Available from: https:\/\/www.who.int\/news-room\/events\/detail\/2024\/09\/26\/default-calendar\/un-general-assembly-high-level-meeting-on-antimicrobial-resistance-2024."},{"key":"1179_CR45","doi-asserted-by":"publisher","first-page":"100306","DOI":"10.1016\/j.lansea.2023.100306","volume":"18","author":"B Sihombing","year":"2023","unstructured":"Sihombing B, Bhatia R, Srivastava R, Aditama TY, Laxminarayan R, Rijal S. Response to antimicrobial resistance in South-East Asia Region. Lancet Reg Health - Southeast Asia. 2023;18:100306.","journal-title":"Lancet Reg Health - Southeast Asia"},{"issue":"1","key":"1179_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s40249-022-01016-5","volume":"11","author":"N Zhou","year":"2022","unstructured":"Zhou N, Cheng Z, Zhang X, Lv C, Guo C, Liu H, et al. Global antimicrobial resistance: a system-wide comprehensive investigation using the Global One Health index. Infect Dis Poverty. 2022;11(1):92.","journal-title":"Infect Dis Poverty"},{"key":"1179_CR47","unstructured":"Pettan-Brewer C Global One-Health debate is not properly balanced | D+C - Development + Cooperation [Internet]. 2023 [cited 2025 May 12]. Available from: https:\/\/www.dandc.eu\/en\/article\/top-down-approaches-dominate-one-health-agenda-high-income-countries-while-bottom."},{"issue":"1","key":"1179_CR48","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12889-024-17766-w","volume":"24","author":"EL Gilham","year":"2024","unstructured":"Gilham EL, Pearce-Smith N, Carter V, Ashiru-Oredope D. Assessment of global antimicrobial resistance campaigns conducted to improve public awareness and antimicrobial use behaviours: a rapid systematic review. BMC Public Health. 2024;24(1):396.","journal-title":"BMC Public Health"},{"issue":"3","key":"1179_CR49","first-page":"253","volume":"13","author":"H Abdel Hadi","year":"2024","unstructured":"Abdel Hadi H, Eltayeb F, Al Balushi S, Daghfal J, Ahmed F, Mateus C. Evaluation of hospital antimicrobial stewardship programs: implementation, process, impact, and outcomes. Rev Systematic Rev Antibiot. 2024;13(3):253.","journal-title":"Rev Systematic Rev Antibiot"},{"issue":"1","key":"1179_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13756-024-01369-6","volume":"13","author":"M Harun","year":"2024","unstructured":"Harun M, Sumon SA, Hasan I, Akther FM, Islam M, Anwar M. Barriers, facilitators, perceptions and impact of interventions in implementing antimicrobial stewardship programs in hospitals of low-middle and middle countries: a scoping review. Antimicrob Resist Infect Control. 2024;13(1):8.","journal-title":"Antimicrob Resist Infect Control"},{"key":"1179_CR51","unstructured":"WHO. Antimicrobial stewardship programmes in health-care facilities in low - and middle -income countries [Internet]. 2019. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241515481."},{"key":"1179_CR52","unstructured":"Shedeed E. Mapping global governance of antibiotic stewardship: a one health multi-level governance approach [Internet]. Universit\u00e9 d\u2019Ottawa | University of Ottawa. 2024. Available from: http:\/\/hdl.handle.net\/10393\/46203."},{"issue":"9","key":"1179_CR53","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/antibiotics11091149","volume":"11","author":"N Kamere","year":"2022","unstructured":"Kamere N, Garwe ST, Akinwotu OO, Tuck C, Krockow EM, Yadav S, et al. Scoping review of national antimicrobial stewardship activities in eight African countries and adaptable recommendations. Antibiotics. 2022;11(9):1149.","journal-title":"Antibiotics"},{"issue":"2","key":"1179_CR54","doi-asserted-by":"publisher","first-page":"dlaf031","DOI":"10.1093\/jacamr\/dlaf031","volume":"7","author":"Z Saleem","year":"2025","unstructured":"Saleem Z, Sheikh S, Godman B, Haseeb A, Afzal S, Qamar MU, et al. Increasing the use of the who AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries. JAC-Antimicrob Resist. 2025;7(2):dlaf031.","journal-title":"JAC-Antimicrob Resist"},{"key":"1179_CR55","unstructured":"UNEG. Evaluating Policy Influence Stocktaking Report | UNEG [Internet]. 2023. Available from: https:\/\/www.unevaluation.org\/uneg_publications\/evaluating-policy-influence-stocktaking-report."},{"issue":"3","key":"1179_CR56","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/1878-0261.12918","volume":"15","author":"A Peruga","year":"2021","unstructured":"Peruga A, L\u00f3pez MJ, Martinez C, Fern\u00e1ndez E. Tobacco control policies in the 21st century: achievements and open challenges. Mol Oncol. 2021;15(3):744\u201352.","journal-title":"Mol Oncol"},{"issue":"Suppl 2","key":"1179_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1017\/jme.2022.78","volume":"50","author":"C Kirchhelle","year":"2022","unstructured":"Kirchhelle C, Podolsky SH. An awkward fit: antimicrobial resistance and the evolution of international health politics (1945-2022). J Law Med Ethics. 2022;50(Suppl 2):40\u201346.","journal-title":"J Law Med Ethics"},{"issue":"1","key":"1179_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12992-024-01015-1","volume":"20","author":"A Ruckert","year":"2024","unstructured":"Ruckert A, Lake S, Van Katwyk SR. Developing a protocol on antimicrobial resistance through WHO\u2019s pandemic treaty will protect lives in future pandemics. Glob Health. 2024;20(1):10.","journal-title":"Glob Health"},{"key":"1179_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijid.2020.09.137","volume":"101","author":"N Gordon","year":"2020","unstructured":"Gordon N, Aggarwal V, Amos B, Buhler C, Huszar A, McKenzie J, et al. The UK Fleming Fund: developing AMR surveillance capacity in low- and middle-income countries. Int J Infect Dis. 2020;101:40.","journal-title":"Int J Infect Dis"},{"key":"1179_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ijid.2020.09.251","volume":"101","author":"N Gordon","year":"2020","unstructured":"Gordon N, Amos B, Azore E, Bastiaens G, Buhler C, Issah S, et al. The UK Fleming Fund: developing microbiology laboratory capacity for AMR surveillance. Int J Infect Dis. 2020;101:86.","journal-title":"Int J Infect Dis"},{"key":"1179_CR61","unstructured":"Fund F. Global Projects [Internet]. Fleming Fund. 2025. Available from: https:\/\/www.flemingfund.org\/grants-funding\/global-projects\/"},{"key":"1179_CR62","unstructured":"GARP. Global Antibiotic Resistance Partnership [Internet]. One Health Trust. 2025. Available from: https:\/\/onehealthtrust.org\/projects\/global-antibiotic-resistance-partnership\/."},{"key":"1179_CR63","unstructured":"USAID. The Medicines, Technologies, and Pharmaceutical Services (MTaPs) Program [Internet]. 2024. Available from: https:\/\/www.mtapsprogram.org\/."},{"issue":"Suppl 1","key":"1179_CR64","first-page":"S33","volume":"23","author":"E Bell","year":"2017","unstructured":"Bell E, Tappero JW, Ijaz K, Bartee M, Fernandez J, Burris H, et al. Joint external evaluation-development and scale-up of global multisectoral health capacity evaluation process. Emerg Infect Dis. 2017;23(Suppl 1):S33\u20139.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"1179_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12992-021-00720-5","volume":"17","author":"A Razavi","year":"2021","unstructured":"Razavi A, Collins S, Wilson A, Okereke E. Evaluating implementation of international health regulations core capacities: using the electronic states parties self-assessment annual reporting tool (e-SPAR) to monitor progress with joint external evaluation indicators. Glob Health. 2021;17(1):69.","journal-title":"Glob Health"},{"issue":"3","key":"1179_CR66","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11205-017-1552-1","volume":"135","author":"DTL Shek","year":"2018","unstructured":"Shek DTL, Wu FKY. The social indicators movement: progress, paradigms, puzzles, promise and potential research directions. Soc Indic Res. 2018;135(3):975\u201390.","journal-title":"Soc Indic Res"},{"key":"1179_CR67","unstructured":"Davis KE, Kingsbury B, Merry SE. Indicators as a technology of global governance | Law & Society Review | Cambridge Core [Internet]. 2012. Available from: https:\/\/www.cambridge.org\/core\/journals\/law-and-society-review\/article\/abs\/indicators-as-a-technology-of-global-governance\/5A3AA5990C17A7900F7D5A3CDFC29F25."},{"key":"1179_CR68","unstructured":"Kelley JG, Simmons BA. The power of global performance indicators [Internet]. 2020. Available from: https:\/\/www.cambridge.org\/universitypress\/subjects\/politics-international-relations\/american-government-politics-and-policy\/power-global-performance-indicators."},{"issue":"1","key":"1179_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1080\/21665095.2014.922890","volume":"1","author":"MG Quibria","year":"2014","unstructured":"Quibria MG. Aid effectiveness: research, policy and unresolved issues. Dev Stud Res. 2014;1(1):75\u201387.","journal-title":"Dev Stud Res"},{"key":"1179_CR70","unstructured":"OECD [Internet]. Applying evaluation criteria thoughtfully. 2021. Available from: https:\/\/www.oecd.org\/en\/publications\/applying-evaluation-criteria-thoughtfully_543e84ed-en.html."},{"issue":"7","key":"1179_CR71","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1136\/jech-2018-211654","volume":"74","author":"A Chiolero","year":"2020","unstructured":"Chiolero A, Buckeridge D. Glossary for public health surveillance in the age of data science. J Epidemiol Community Health. 2020;74(7):612\u201316.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1179_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.healthpol.2014.01.007","volume":"116","author":"E Barbazza","year":"2014","unstructured":"Barbazza E, Tello JE. A review of health governance: definitions, dimensions and tools to govern. Health Policy Amst Neth. 2014;116(1):1\u201311.","journal-title":"Health Policy Amst Neth"},{"key":"1179_CR73","unstructured":"WHO. Monitoring the building blocks of health systems: a handbook of indicators and their measurement strategies [Internet]. 2010. Available from: http:\/\/archive.org\/details\/WHOMBHSS2010FullWeb."}],"container-title":["Globalization and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12992-025-01179-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12992-025-01179-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T13:52:10Z","timestamp":1768917130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12992-025-01179-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1179"],"URL":"https:\/\/doi.org\/10.1186\/s12992-025-01179-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6933172\/v1","asserted-by":"object"}]},"ISSN":["1744-8603"],"issn-type":[{"value":"1744-8603","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"19 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not sought for the present study because it is a retrospective review exclusively using public domain data. Consent to participate was not sought because there were no human participants and no personally identifiable data are involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors of this paper are currently or have in the past been engaged in delivering the independent evaluation of the UK Fleming Fund. The independent evaluation of the UK Fleming Fund is delivered under contract between the UK Department of Health and Social Care (DHSC) and Itad Ltd. Authors\u2019 engagement for these purposes is as follows: Archie Drake, Syed Abbas, Rebecca Maudling, Ankur Gupta-Wright and Tim Shorten are independent consultants currently engaged by Itad under contract. Isabel Sassoon and Alan Serrano-Rico have received funding from Itad Ltd. through Brunel Talent Marketplace (a non-profit division of Brunel University). Jennifer Armitage is currently engaged by LAMP Development Ltd under subcontract from Itad Ltd. Anila Shafa is a current employee of Itad Ltd. The objectives of this study are consistent with the scope of the independent evaluation of the UK Fleming Fund. In addition to the interests detailed above. Tim Shorten is an editor for Globalization and Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}